|
Index of reports
> Cases resulting in a serious event (101)
> Cases with Neutropenia (8)
Below is the selection of adverse event reports related to Zerit (Stavudine) that includes cases resulting in a serious event where reactions include neutropenia.
Adverse event in 37 year old male receiving Zerit (Stavudine)
Reported by a physician from Japan on 2007-06-18
Patient: 37 year old male
Adverse reactions / side effects: Neutropenia, Rash, Cerebral Toxoplasmosis, Herpes Zoster
Adverse event resulted in: hospitalization
Suspect drug(s):
Baktar
Administration route: Oral
Start date: 2005-03-12
End date: 2005-04-06
Denosine IV
Dosage: form reported as i.v. infusion.
Indication: Cytomegalovirus Enterocolitis
Start date: 2005-03-11
End date: 2005-03-29
Denosine IV
Dosage: form reported as i.v. infusion.
Start date: 2005-04-19
End date: 2005-04-24
Epivir
Administration route: Oral
Indication: HIV Infection
Start date: 2005-03-29
End date: 2005-05-06
Epivir
Administration route: Oral
Start date: 2005-06-10
Kaletra
Administration route: Oral
Indication: HIV Infection
Start date: 2005-03-29
End date: 2005-05-06
Kaletra
Administration route: Oral
Start date: 2005-06-10
Lectisol
Dosage: reported as lectisol (diaphenylsulfone).
Administration route: Oral
Start date: 2005-06-23
End date: 2005-06-28
Valixa
Administration route: Oral
Indication: Cytomegalovirus Enterocolitis
Start date: 2005-04-25
End date: 2005-05-17
Valixa
Dosage: maintenance threrapy.
Administration route: Oral
Start date: 2005-05-18
End date: 2005-07-21
Zerit
Dosage: reported as zerit (sanilvudine).
Administration route: Oral
Indication: HIV Infection
Start date: 2005-03-29
End date: 2005-05-06
Zerit
Dosage: reported as zerit (sanilvudine).
Administration route: Oral
Start date: 2005-06-10
End date: 2006-03-23
Other drugs received by patient: Pentamidine Isethionate; Cortril; Diflucan; Fungizone; Zithromac; Pyrimethamine TAB; Clindamycin Hydrochloride; Calcium Folinate; Lenograstim; Prednisolone
Adverse event in female receiving Zerit (Stavudine)
Reported by a consumer/non-health professional from United States on 2007-06-14
Patient: female
Adverse reactions / side effects: Electroencephalogram Abnormal, Cerebral Disorder, Drug Exposure During Pregnancy, Rhinitis, Neutropenia, Foetal Growth Retardation, Anaemia Macrocytic
Adverse event resulted in: hospitalization
Suspect drug(s):
Crixivan
Dosage: ongoing gestational week 2 through 10
Indication: HIV Test Positive
Start date: 1997-05-29
End date: 1997-07-01
Epivir
Dosage: initiated at gestational week 29
Indication: HIV Test Positive
Start date: 1997-11-12
End date: 1998-01-19
Epivir
Dosage: 6 week course after birth
Administration route: Oral
Indication: Prophylaxis Against HIV Infection
Start date: 1998-01-01
End date: 1998-03-01
Fortovase
Dosage: initiated at gestational week 29
Indication: HIV Test Positive
Start date: 1997-11-12
End date: 1998-01-19
Retrovir
Dosage: initiated at gestational week 10
Indication: HIV Test Positive
Start date: 1997-07-01
End date: 1998-01-19
Retrovir
Dosage: infusion at delivery
Administration route: Oral
Indication: Prophylaxis Against HIV Infection
Start date: 1998-01-01
End date: 1998-03-01
Videx
Dosage: ongoing at gestational weeks 2 through 10
Indication: HIV Infection
Start date: 1997-05-29
End date: 1997-07-01
Zerit
Dosage: ongoing gestational weeks 2 through 10
Indication: HIV Test Positive
Start date: 1997-05-29
End date: 1997-07-01
Adverse event in female receiving Zerit (Stavudine)
Reported by a health professional (non-physician/pharmacist) from United States on 2007-06-08
Patient: female
Adverse reactions / side effects: Cerebral Disorder, Rhinitis, Neutropenia, Foetal Growth Retardation, Pregnancy, Anaemia Macrocytic
Adverse event resulted in: hospitalization
Suspect drug(s):
Crixivan
Dosage: exposure began in week two of gestation.
Indication: HIV Test Positive
Start date: 1997-05-29
End date: 1997-07-01
Epivir
Dosage: exposure began in week 29 of gestation.
Indication: HIV Test Positive
Start date: 1997-11-12
End date: 1998-01-19
Fortovase
Dosage: exposure began in week 29 of gestation.
Indication: HIV Test Positive
Start date: 1997-11-12
End date: 1998-01-19
Lamivudine
Administration route: Oral
Indication: Prophylaxis Against HIV Infection
Start date: 1998-01-01
End date: 1998-03-01
Retrovir
Dosage: exposure began in week ten of gestation.
Indication: HIV Test Positive
Start date: 1997-07-01
End date: 1998-01-19
Videx
Dosage: exposure began in week two of gestation.
Indication: HIV Test Positive
Start date: 1997-05-29
End date: 1997-07-01
Zerit
Dosage: exposure began in week two of gestation.
Indication: HIV Test Positive
Start date: 1997-05-29
End date: 1997-07-01
Zidovudine
Indication: HIV Infection
Start date: 1997-01-01
End date: 1997-01-01
Zidovudine
Administration route: Oral
Indication: Prophylaxis Against HIV Infection
Start date: 1998-01-01
End date: 1998-03-01
Adverse event in female receiving Zerit (Stavudine)
Reported by a health professional (non-physician/pharmacist) from United States on 2007-05-30
Patient: female
Adverse reactions / side effects: Cerebral Disorder, Rhinitis, Neutropenia, Foetal Growth Retardation, Pregnancy, Anaemia Macrocytic
Adverse event resulted in: hospitalization
Suspect drug(s):
Crixivan
Dosage: exposure began in week two of gestation.
Indication: HIV Test Positive
Start date: 1997-05-29
End date: 1997-07-01
Epivir
Dosage: exposure began in week 29 of gestation.
Indication: HIV Test Positive
Start date: 1997-11-12
End date: 1998-01-19
Fortovase
Dosage: exposure began in week 29 of gestation.
Indication: HIV Test Positive
Start date: 1997-11-12
End date: 1998-01-19
Lamivudine
Administration route: Oral
Indication: Prophylaxis Against HIV Infection
Start date: 1998-01-01
End date: 1998-03-01
Retrovir
Dosage: exposure began in week ten of gestation.
Indication: HIV Test Positive
Start date: 1997-07-01
End date: 1998-01-19
Videx
Dosage: exposure began in week two of gestation.
Indication: HIV Test Positive
Start date: 1997-05-29
End date: 1997-07-01
Zerit
Dosage: exposure began in week two of gestation.
Indication: HIV Test Positive
Start date: 1997-05-29
End date: 1997-07-01
Zidovudine
Indication: HIV Infection
Start date: 1997-01-01
End date: 1997-01-01
Zidovudine
Administration route: Oral
Indication: Prophylaxis Against HIV Infection
Start date: 1998-01-01
End date: 1998-03-01
Adverse event in female receiving Zerit (Stavudine)
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2007-05-25
Patient: female, weighing 3.0 kg (6.6 pounds)
Adverse reactions / side effects: Abdominal Pain, Blood Creatine Phosphokinase Increased, Hyperlactacidaemia, Flatulence, Mucous Stools, Platelet Count Increased, Hypercholesterolaemia, Hepatomegaly, Malaise, Obesity, Abdominal Distension, Hypertriglyceridaemia, Oxygen Saturation Decreased, Anaemia, Ventricular Tachycardia, Hypotonia, Neutropenia
Adverse event resulted in: hospitalization
Suspect drug(s):
Fortovase
Dosage: received from week 27 of gestation to delivery
Invirase
Dosage: initiated at 27 weeks of gestation
Indication: HIV Infection
Norvir
Dosage: received from week 27 of gestation to delivery
Retrovir
Dosage: received 6 weeks of antiretroviral therapy after delivery, 200mg/20ml
Retrovir
Dosage: received from conception to day 3 of gestation and from week 27 of gestation to and at delivery.
Sustiva
Videx
Dosage: received from conception to day 3 of gestation, then from week 27 of gestation to delivery
Viramune
Dosage: received one single oral dose, from 27 weeks gestation transplacental exposure
Administration route: Oral
Indication: HIV Infection
Viramune
Dosage: received infusion during delivery,
Zerit
Other drugs received by patient: Cordarone; Speciafoldine; Ferrostrane; Uvesterol D; Fluorex; AZT
Adverse event in 37 year old male receiving Zerit (Stavudine)
Reported by a physician from Japan on 2007-04-26
Patient: 37 year old male
Adverse reactions / side effects: Dysgeusia, Liver Function Test Abnormal, General Physical Health Deterioration, Neutropenia, Infection
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Baktar
Administration route: Oral
Indication: Pneumocystis Jiroveci Pneumonia
Start date: 2006-03-23
End date: 2006-04-27
Diflucan
Dosage: 100mg per day
Administration route: Oral
Indication: Oral Candidiasis
Start date: 2006-04-13
End date: 2006-05-10
Epivir
Dosage: 150mg twice per day
Administration route: Oral
Indication: HIV Infection
Start date: 2006-04-06
End date: 2006-04-22
Epzicom
Administration route: Oral
Indication: HIV Infection
Start date: 2006-05-11
Kaletra
Administration route: Oral
Indication: HIV Infection
Start date: 2006-04-06
End date: 2006-04-22
Zerit
Dosage: 30mg per day
Administration route: Oral
Indication: HIV Infection
Start date: 2006-04-06
End date: 2006-04-22
Other drugs received by patient: Stocrin; Itraconazole; Gaster; Predonine; Myslee; Fungizone; Benambax
Adverse event in 37 year old male receiving Zerit (Stavudine)
Reported by a physician from Japan on 2007-04-05
Patient: 37 year old male
Adverse reactions / side effects: Neutropenia, Rash, Cerebral Toxoplasmosis, Herpes Zoster
Adverse event resulted in: hospitalization
Suspect drug(s):
Baktar
Administration route: Oral
Start date: 2005-03-12
End date: 2005-04-06
Denosine IV
Dosage: form reported as i.v. infusion.
Indication: Cytomegalovirus Enterocolitis
Start date: 2005-03-11
End date: 2005-03-29
Denosine IV
Dosage: form reported as i.v. infusion.
Start date: 2005-04-19
End date: 2005-04-24
Epivir
Administration route: Oral
Indication: HIV Infection
Start date: 2005-03-29
End date: 2005-05-06
Epivir
Administration route: Oral
Start date: 2005-06-10
Kaletra
Administration route: Oral
Indication: HIV Infection
Start date: 2005-03-29
End date: 2005-05-06
Kaletra
Administration route: Oral
Start date: 2005-06-10
Lectisol
Dosage: reported as lectisol (diaphenylsulfone).
Administration route: Oral
Start date: 2005-06-23
End date: 2005-06-28
Valixa
Administration route: Oral
Indication: Cytomegalovirus Enterocolitis
Start date: 2005-04-25
End date: 2005-05-17
Valixa
Dosage: maintenance threrapy.
Administration route: Oral
Start date: 2005-05-18
End date: 2005-07-21
Zerit
Dosage: reported as zerit (sanilvudine).
Administration route: Oral
Indication: HIV Infection
Start date: 2005-03-29
End date: 2005-05-06
Zerit
Dosage: reported as zerit (sanilvudine).
Administration route: Oral
Start date: 2005-06-10
End date: 2006-03-23
Other drugs received by patient: Pentamidine Isethionate; Cortril; Diflucan; Fungizone; Zithromac; Pyrimethamine TAB; Clindamycin Hydrochloride; Calcium Folinate; Lenograstim; Prednisolone
Adverse event in 37 year old male receiving Zerit (Stavudine)
Reported by a physician from Japan on 2007-02-20
Patient: 37 year old male
Adverse reactions / side effects: Neutropenia, Rash, Cerebral Toxoplasmosis, Herpes Zoster
Adverse event resulted in: hospitalization
Suspect drug(s):
Baktar
Administration route: Oral
Start date: 2005-03-12
End date: 2005-04-06
Denosine IV
Dosage: form reported as i.v. infusion.
Indication: Cytomegalovirus Enterocolitis
Start date: 2005-03-11
End date: 2005-03-29
Denosine IV
Dosage: form reported as i.v. infusion.
Start date: 2005-04-19
End date: 2005-04-24
Epivir
Administration route: Oral
Indication: HIV Infection
Start date: 2005-03-29
End date: 2005-05-06
Epivir
Administration route: Oral
Start date: 2005-06-10
Kaletra
Administration route: Oral
Indication: HIV Infection
Start date: 2005-03-29
End date: 2005-05-06
Kaletra
Administration route: Oral
Start date: 2005-06-10
Lectisol
Dosage: reported as lectisol (diaphenylsulfone).
Administration route: Oral
Start date: 2005-06-23
End date: 2005-06-28
Valixa
Administration route: Oral
Indication: Cytomegalovirus Enterocolitis
Start date: 2005-04-25
End date: 2005-05-17
Valixa
Dosage: maintenance threrapy.
Administration route: Oral
Start date: 2005-05-18
End date: 2005-07-21
Zerit
Dosage: reported as zerit (sanilvudine).
Administration route: Oral
Indication: HIV Infection
Start date: 2005-03-29
End date: 2005-05-06
Zerit
Dosage: reported as zerit (sanilvudine).
Administration route: Oral
Start date: 2005-06-10
End date: 2006-03-23
Other drugs received by patient: Pentamidine Isethionate; Cortril; Diflucan; Fungizone; Zithromac; Pyrimethamine TAB; Clindamycin Hydrochloride; Calcium Folinate; Lenograstim; Prednisolone
|
